Journals / Anatolian Current Medical Journal / 2026 / Volume: 8 Issue: 3

Inflammatory and nutritional indices in patients with pheochromocytoma

Belma Özlem Tural Balsak(Ankara Bilkent City Hospital)0000-0002-1348-7706
Muzaffer Deniz(Ankara Bilkent City Hospital)0000-0002-8905-3955
Narin Nasıroğlu İmga(University of Health Sciences, Department of Endocrinology)0000-0001-8013-230X
Neslihan Çuhacı Seyrek(Ankara Yildirim Beyazit University, Faculty of Medicine, Department of Endocrinology)0000-0003-1042-3640
Oya Topaloğlu(Ankara Yildirim Beyazit University, Faculty of Medicine, Department of Endocrinology)0000-0003-2501-935X
Reyhan Ersoy(Ankara Yildirim Beyazit University, Faculty of Medicine, Department of Endocrinology)0000-0002-7437-1176
Bekir Çakır(Ankara Yildirim Beyazit University, Faculty of Medicine, Department of Endocrinology)0000-0001-7526-8827
Pages
—
Publication Date
2026-05-22
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although overall nutritional indices were not significantly altered, the inverse association between PNI and tumor burden suggests that catecholamine excess may adversely affect immune-nutritional status.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: Pheochromocytoma is characterized by catecholamine excess, which may influence immune regulation and metabolic pathways.
📊
Key Findings & Data:Methods: In this retrospective study, 39 patients with pheochromocytoma were compared with 24 age-, sex-, and body mass index-matched healthy control subjects.
💡
Conclusion & Impact:Although overall nutritional indices were not significantly altered, the inverse association between PNI and tumor burden suggests that catecholamine excess may adversely affect immune-nutritional status.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Pheochromocytoma · catecholamines · systemic immune-inflammation index

Abstract

Aims: Pheochromocytoma is characterized by catecholamine excess, which may influence immune regulation and metabolic pathways. However, the relationship between catecholamine activity, systemic inflammation, and immune-nutritional status remains incompletely understood. This study aimed to evaluate inflammatory and nutritional indices in patients with pheochromocytoma and to investigate their association with tumor size and plasma metanephrine levels. Methods: In this retrospective study, 39 patients with pheochromocytoma were compared with 24 age-, sex-, and body mass index-matched healthy control subjects. Complete blood count parameters and inflammation-based indices, including neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), Prognostic Nutritional Index (PNI), and Controlling Nutritional Status (CONUT) score, were analyzed. Correlation analyses were performed to assess the relationships between inflammatory indices, plasma metanephrine levels, and tumor size. Results: Patients with pheochromocytoma had significantly higher WBC, neutrophil, and platelet counts than controls. SII was significantly elevated, whereas NLR, CONUT, and PNI did not differ between groups. Fasting glucose levels were higher in the pheochromocytoma group, while lipid parameters were comparable. Correlation analyses demonstrated PNI was negatively correlated with both tumor size and plasma metanephrine levels. SII showed positive correlations with NLR and PNI, and CONUT was positively correlated with NLR. Conclusion: Pheochromocytoma is associated with systemic inflammatory activation, as reflected by elevated leukocyte parameters and increased SII. Although overall nutritional indices were not significantly altered, the inverse association between PNI and tumor burden suggests that catecholamine excess may adversely affect immune-nutritional status. These findings highlight the complex immune-metabolic interplay in pheochromocytoma.

🔖

Cite This Article

Balsak, B. Ö. T., Deniz, M., İmga, N. N., Seyrek, N. Ç., Topaloğlu, O., Ersoy, R., Çakır, B. (2026). Inflammatory and nutritional indices in patients with pheochromocytoma. Anatolian Current Medical Journal, Volume: 8 Issue: 3. https://doi.org/10.38053/acmj.1900323

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915-1942. doi:10.1210/jc.2014-1498
  2. Zuber SM, Kantorovich V, Pacak K. Hypertension in pheochromocytoma: characteristics and treatment. Endocrinol Metab Clin North Am. 2011; 40(2):295-vii. doi:10.1016/j.ecl.2011.02.002
  3. Zhang W, Yu J, Chen Y, et al. Glucose disorders in patients with pheochromocytoma/paraganglioma: profile and influence effects in a large cohort with 705 patients. Endocr Pract. 2025;31(3):269-277. doi:10. 1016/j.eprac.2024.11.004
  4. Zhang W, Zhou Y, Cui Y, et al. An in-depth exploration of the catecholamine and dyslipidemia relationship in pheochromocytoma and paraganglioma patients: a large Chinese cohort study. Endocrine. 2025;89(2):595-602. doi:10.1007/s12020-025-04277-w
  5. Pongratz G, Straub RH. The sympathetic nervous response in inflammation. Arthritis Res Ther. 2014;16(6):504. doi:10.1186/s13075-014-0504-2
  6. Bergmann M, Sautner T. Immunomodulatory effects of vasoactive catecholamines. Wien Klin Wochenschr. 2002;114(17-18):752-761.
  7. Zheng K, Liu X, Ji W, Lu J, Cui J, Li W. The efficacy of different inflammatory markers for the prognosis of patients with malignant tumors. J Inflamm Res. 2021;14:5769-5785. doi:10.2147/JIR.S334941
  8. Yang R, Chang Q, Meng X, Gao N, Wang W. Prognostic value of Systemic immune-inflammation index in cancer: a meta-analysis. J Cancer. 2018;9(18):3295-3302. doi:10.7150/jca.25691
  9. Zhang Y, Tang M, Gu QH, Zhou LN, Chen MB. The prognostic value of combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) in solid tumor. Cancer Manag Res. 2025;17:1351-1359. doi:10.2147/CMAR.S523419
  10. Ignacio de Ulíbarri J, González-Madroño A, de Villar NG, et al. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp. 2005;20(1):38-45.
  11. Kuroda D, Sawayama H, Kurashige J, et al. Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection. Gastric Cancer. 2018;21(2):204-212. doi:10.1007/s10120-017-0744-3
  12. Zelinka T, Petrák O, Strauch B, et al. Elevated inflammation markers in pheochromocytoma compared to other forms of hypertension. Neuroimmunomodulation. 2007;14(1):57-64. doi:10.1159/000107289
  13. Mochizuki T, Kawahara T, Takamoto D, et al. The neutrophil-to-lymphocyte ratio (NLR) predicts adrenocortical carcinoma and is correlated with the prognosis. BMC Urol. 2017;17(1):49. doi:10.1186/s12894-017-0240-4
  14. Parazzoli C, Prete A, Favero V, et al. Inflammation-Based Scores in Patients With Pheochromocytoma. J Clin Endocrinol Metab. 2025; 110(3):e630-e640. doi:10.1210/clinem/dgae284
  15. Derrou S, Bouziane T, Salhi H, El Ouahabi H. Pheochromocytoma and glucoregulation disorders. Ann Afr Med. 2021;20(1):42-45. doi:10.4103/aam.aam_13_20